← back to search

Ramiro Ribeiro

Apellis Pharmaceuticals (United States) · US
Area of research
Ophthalmology · Molecular Biology
Research interest
Research interests include Retinal Diseases and Treatments, Retinal Development and Disorders, Retinal and Macular Surgery, and Glaucoma and retinal disorders.
h-index
19
citations
1,990
works
51
NIH funding
primary concept
Medicine
email

Recent publications

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
The Lancet 2023cited by 420position: middledoi
Association of Pegcetacoplan With Progression of Incomplete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration
JAMA Ophthalmology 2022cited by 63position: middledoi
Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy
Scientific Reports 2022cited by 38position: middledoi
New approaches to the treatment of Age-Related Macular Degeneration (AMD)
Experimental Eye Research 2022cited by 14position: middledoi
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy
Ophthalmology 2021cited by 88position: lastdoi
Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan
American Journal of Ophthalmology 2021cited by 48position: middledoi
Deliberations of an International Panel of Experts on OCT Angiography Nomenclature of Neovascular Age-Related Macular Degeneration
Ophthalmology 2020cited by 24position: middledoi
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration
Ophthalmology 2019cited by 505position: middledoi
Subretinal Implantation of Retinal Pigment Epithelial Cells Derived From Human Embryonic Stem Cells: Improved Survival When Implanted as a Monolayer
Investigative Ophthalmology & Visual Science 2013cited by 244position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Philip J. Rosenfeld · University of Miami4 papers (2019–2022)Nadia K. Waheed · Astellas Pharma (United States)3 papers (2021–2022)Ravi Metlapally · Apellis Pharmaceuticals (United States)3 papers (2021–2022)Frank G. Holz · Tsinghua University2 papers (2022–2022) · 2 papers (2019–2021)Charles C. Wykoff · Nune Eye Hospital2 papers (2019–2021)Jason S. Slakter · NYU Langone Health2 papers (2019–2021) · 2 papers (2021–2021)Jordi Monés · Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine2 papers (2021–2021)Giovanni Staurenghi · University of Sheffield2 papers (2021–2022)Cedric Francois · Apellis Pharmaceuticals (United States)1 papers (2019–2019) · 1 papers (2019–2019) · 1 papers (2022–2022)Lawrence J. Singerman · Case Western Reserve University1 papers (2019–2019)Christine A. Curcio · Vanderbilt University1 papers (2022–2022)Ayesha Karamat · George Mason University1 papers (2022–2022)Sophiana Lindenberg · Doheny Eye Institute1 papers (2022–2022)Robert F. Mullins · University of Iowa1 papers (2022–2022)Maximilian Pfau · Berlin Institute of Health at Charité - Universitätsmedizin Berlin1 papers (2022–2022)Srinivas R. Sadda · University of California, Los Angeles1 papers (2022–2022)